StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Zydus Lifesciences Limited
NSE:ZYDUSLIFE.NS
Sector
Location
Market Cap
USD 11.70 B
Share Price
USD 11.62
Avg Daily Volume
1,461,866
Change (1 day)
-0.04%
Change (1 year)
-11.39%
Change (YTD)
2.37%
Zydus Lifesciences Limited Free Cash Flow for the year ending March 31, 2025: USD 592.60 M
Zydus Lifesciences Limited Free Cash Flow is USD 592.60 M for the year ending March 31, 2025, a 112.94% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Zydus Lifesciences Limited Free Cash Flow for the year ending March 31, 2024 was USD 278.30 M, a 37.97% change year over year.
-
Zydus Lifesciences Limited Free Cash Flow for the year ending March 31, 2023 was USD 201.72 M, a 69.90% change year over year.
-
Zydus Lifesciences Limited Free Cash Flow for the year ending March 31, 2022 was USD 118.73 M, a -64.36% change year over year.
-
Zydus Lifesciences Limited Free Cash Flow for the year ending March 31, 2021 was USD 333.09 M, a 56.76% change year over year.
Competitors
Mankind Pharma Limited
USD 27.80
MANKIND.NS
-0.05
-0.18%
Ipsen S.A.
USD 122.70
IPN.PA
+0.63
0.52%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
+0.00
0.46%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.01
-0.31%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
Mankind Pharma Limited
USD 27.80
MANKIND.NS
-0.05
-0.18%
Ipsen S.A.
USD 122.70
IPN.PA
+0.63
0.52%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
+0.00
0.46%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.01
-0.31%
Eli Lilly and Company
USD 779.28
LLY
+3.38
0.44%
AbbVie Inc.
USD 190.75
ABBV
+0.76
0.40%
Novo Nordisk A/S
USD 69.62
NOVO-B.CO
+0.45
0.65%
Roche Holding AG
USD 347.68
RO.SW
-0.20
-0.06%
Novartis AG
USD 123.90
NOVN.SW
+0.42
0.34%
Abbott Laboratories
USD 134.11
ABT
-2.15
-1.58%
AstraZeneca PLC
USD 141.63
AZN.L
-1.32
-0.93%
Merck & Co., Inc.
USD 82.39
MRK
+0.58
0.71%
Thermo Fisher Scientific Inc.
USD 427.76
TMO
+6.29
1.49%
Amgen Inc.
USD 296.85
AMGN
+6.33
2.18%
Pfizer Inc.
USD 25.32
PFE
+0.28
1.12%
Gilead Sciences, Inc.
USD 111.51
GILD
-0.22
-0.20%
Sanofi
USD 98.65
SAN.PA
+0.57
0.58%
Vertex Pharmaceuticals Incorporated
USD 457.03
VRTX
+4.87
1.08%
Bristol-Myers Squibb Company
USD 47.63
BMY
+0.12
0.25%
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%